Autolus Therapeutics PLC (NASDAQ:AUTL)
| 1.85 BATS BZX Real-Time Price As of 11:13am ET |  -0.01 / -0.54%Today’s Change | 1.60 Today|||52-Week Range 4.73 | -2.63% Year-to-Date |
Latest AUTL News | Press Releases
No recent news for Autolus Therapeutics PLC.
Today’s Trading
| Previous close | 1.86 |
| Today’s open | 1.89 |
| Day’s range | 1.83 - 1.89 |
| Volume | 5,514 |
| Average volume (3 months) | 646,182 |
| Market cap | $370.4M |
Data as of 11:13am ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | +20.52% |
| Earnings growth (this year) | +37.10% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +311.02% |
| P/E ratio | NM |
| Price/Sales | 29.14 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VYGRVoyager Therapeutics... | +0.10 | +1.35% |
| WVEWAVE Life Sciences L... | -0.12 | -3.16% |
| NGMNGM Biopharmaceutica... | +0.09 | +2.36% |
| BNGOBionano Genomics Inc | +0.03 | +2.75% |
Data as of 11:30am ET, 03/23/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $6.2M |
| Annual profit (last year) | -$148.8M |
| Net profit margin | -2,402.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
